Schott Pharma AG & CO KGaA annual gross margin
2020
2021
2022
2023
2024
2025
Schott Pharma AG & CO KGaA Gross Margin Growth & History (1SXP)
Schott Pharma AG & CO KGaA's gross margin was 33.71% for fiscal 2025.
View full Schott Pharma AG & CO KGaA company overviewSchott Pharma AG & CO KGaA annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-09-30 | 33.71% | +0.00 pp |
| 2024 | 2024-09-30 | 33.71% | −1.51 pp |
| 2023 | 2023-09-30 | 35.22% | −0.88 pp |
| 2022 | 2022-09-30 | 36.10% | +1.23 pp |
| 2021 | 2021-09-30 | 34.87% | +1.32 pp |
| 2020 | 2020-09-30 | 33.55% | — |
Schott Pharma AG & CO KGaA gross margin trends
Over the last five fiscal years, Schott Pharma AG & CO KGaA's gross margin increased from 33.55% to 33.71%, a change of +0.16 percentage points.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as reported gross profit divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Schott Pharma AG & CO KGaA source filings ↗